Randomized Phase 1 Trial of Pembrolizumab with Sequential Versus Concomitant Stereotactic Body Radiotherapy in Metastatic Urothelial Carcinoma-Reference-Cited by-同舟云学术

Randomized Phase 1 Trial of Pembrolizumab with Sequential Versus Concomitant Stereotactic Body Radiotherapy in Metastatic Urothelial Carcinoma

Published:2019-05 Issue:5 Volume:75 Page:707-711
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Sundahl Nora,Vandekerkhove Gillian,Decaestecker Karel,Meireson Annabel,De Visschere Pieter,Fonteyne Valérie,De Maeseneer Daan,Reynders Dries,Goetghebeur Els,Van Dorpe Jo,Verbeke Sofie,Annala Matti,Brochez Lieve,Van der Eecken Kim,Wyatt Alexander W.,Rottey Sylvie,Ost Piet

Publisher

Elsevier BV

Subject

Urology

Reference8 articles.

1. First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study;Balar;Lancet Oncol,2017

2. Pembrolizumab as second-line therapy for advanced urothelial carcinoma;Bellmunt;N Engl J Med,2017

3. Radiotherapy combination opportunities leveraging immunity for the next oncology practice;Herrera;CA Cancer J Clin,2017

4. Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade;Dovedi;Cancer Res,2014

5. Safety and clinical activity of pembrolizumab and multisite stereotactic body radiotherapy in patients with advanced solid tumors;Luke;J Clin Oncol,2018

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Radiotherapy as a Promising Alternative for Managing Advanced Upper Tract Urothelial Carcinoma: Rescuing Chemotherapy-Intolerant Patients;Clinical Genitourinary Cancer;2024-12

2. Outcomes of radical radiotherapy for the treatment of localized renal pelvic and ureteral carcinoma intolerant to surgery: a real-world study;Clinical Genitourinary Cancer;2024-09

3. Radiotherapy plus pembrolizumab for advanced urothelial carcinoma: results from the ARON-2 real-world study;Scientific Reports;2024-08-27

4. The future of cancer treatment: combining radiotherapy with immunotherapy;Frontiers in Molecular Biosciences;2024-07-09

5. Advancements in Urothelial Cancer Care: Optimizing Treatment for Your Patient;American Society of Clinical Oncology Educational Book;2024-06